These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14984453)

  • 21. When basal insulin therapy in type 2 diabetes mellitus is not enough--what next?
    Raccah D; Bretzel RG; Owens D; Riddle M
    Diabetes Metab Res Rev; 2007 May; 23(4):257-64. PubMed ID: 17315242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-glycemic effects of insulin therapy: a comparison between insulin aspart and regular human insulin during two consecutive meals in patients with type 2 diabetes.
    Sourij H; Schmoelzer I; de Campo A; Tripolt NJ; Stojakovic T; Scharnagl H; Kettler-Schmut E; Forst T; Wascher TC
    Eur J Endocrinol; 2011 Aug; 165(2):269-74. PubMed ID: 21606190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes.
    Gredal C; Rosenfalck A; Dejgaard A; Hilsted J
    Diabetes Res Clin Pract; 2008 May; 80(2):293-8. PubMed ID: 18304675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.
    Sawada T; Tsubata H; Hashimoto N; Takabe M; Miyata T; Aoki K; Yamashita S; Oishi S; Osue T; Yokoi K; Tsukishiro Y; Onishi T; Shimane A; Taniguchi Y; Yasaka Y; Ohara T; Kawai H; Yokoyama M
    Cardiovasc Diabetol; 2016 Aug; 15(1):121. PubMed ID: 27565734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The postprandial state does not impair endothelial function in women with type 2 diabetes irrespective of glycaemic control.
    Strey CH; Young J; Collier M; Florkowski CM; Shand BI; Scott RS
    Diabetologia; 2004 Oct; 47(10):1838-46. PubMed ID: 15502920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men.
    Marchesi S; Lupattelli G; Schillaci G; Pirro M; Siepi D; Roscini AR; Pasqualini L; Mannarino E
    Atherosclerosis; 2000 Dec; 153(2):397-402. PubMed ID: 11164429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic patients with coronary heart disease (J-MACH) -.
    Hiki M; Shimada K; Kiyanagi T; Fukao K; Hirose K; Ohsaka H; Fukushima Y; Kume A; Matsumori R; Sumiyoshi K; Miyazaki T; Ohmura H; Kurata T; Miida T; Daida H
    Circ J; 2010 Jul; 74(7):1471-8. PubMed ID: 20519875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
    Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
    Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The comparison of insulin aspart and human soluble insulin used in insulin pump therapy in newly diagnosed type 2 diabetic patients].
    Li YB; Liu J; Liao ZH; Liao Y; Deng WP; Weng JP
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2472-6. PubMed ID: 16321271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits.
    Coscelli C; Iacobellis G; Calderini C; Carleo R; Gobbo M; Di Mario U; Leonetti F; Galluzzo A; Pirrone V; Lunetta M; Casale P; Paleari F; Falcelli C; Valle D; Camporeale A; Merante D
    Acta Diabetol; 2003 Dec; 40(4):187-92. PubMed ID: 14740279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study.
    Shimabukuro M; Higa N; Chinen I; Yamakawa K; Takasu N
    J Clin Endocrinol Metab; 2006 Mar; 91(3):837-42. PubMed ID: 16368744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
    Bi YF; Zhao LB; Li XY; Wang WQ; Sun SY; Chen YH; Hong J; Su TW; Liu JM; Ning G
    Chin Med J (Engl); 2007 Oct; 120(19):1700-3. PubMed ID: 17935674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved endothelial function with metformin in type 2 diabetes mellitus.
    Mather KJ; Verma S; Anderson TJ
    J Am Coll Cardiol; 2001 Apr; 37(5):1344-50. PubMed ID: 11300445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics.
    Ceriello A; Esposito K; Ihnat M; Thorpe J; Giugliano D
    Diabet Med; 2010 Aug; 27(8):911-7. PubMed ID: 20653749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of post-prandial changes in flow-mediated dilatation in patients with type 2 diabetes with and without macroalbuminuria.
    Shand BI; Scott RS; Florkowski CM; Reynolds ; Ikram H
    Diabetes Nutr Metab; 2001 Aug; 14(4):201-6. PubMed ID: 11716289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fast-acting insulin - new developments towards more flexibility for the patient].
    Schmeisl GW; Kretzschmar Y
    MMW Fortschr Med; 2016 Dec; 158(Suppl 6):5-11. PubMed ID: 27933575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insulin therapy].
    Brunetti P
    Minerva Endocrinol; 2001 Jun; 26(2):65-86. PubMed ID: 11479436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.
    Hirao K; Maeda H; Urata S; Takisawa Y; Hirao S; Sasako T; Sasaki T
    Clin Ther; 2007 May; 29(5):927-934. PubMed ID: 17697911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of effects of α-Glucosidase inhibitors and glinide drugs on endothelial dysfunction in diabetic patients with coronary artery disease.
    Sawada T; Shiotani H; Terashita D; Nagasawa Y; Kim SS; Koide M; Yokoyama M
    Circ J; 2014; 78(1):248-55. PubMed ID: 24225338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.